Common variants of APOE are associated with anti-epileptic drugs resistance in Han Chinese patients

References

• Weber YG, Lerche H. Genetic mechanisms in idiopathic epilepsies. Dev Med Child Neurol 2008;50(9):648–54.
   PubMed Web of Science ®Google Scholar
• Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet 2006;367(9516):1087–100.
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. Early identification of refractory epilepsy. New England J Med 2000;342(5):314–19.
   PubMed Web of Science ®Google Scholar
• Beck H, Yaari Y. Antiepileptogenesis, plasticity of AED targets, drug resistance, and targeting the immature brain. Jasper's Basic Mechanic Epilepsy. 2012;2(1):1–4.
   Google Scholar
• Noebels JL, Avoli M, Rogawski M, et al. “Jasper's basic mechanisms of the epilepsies” workshop. Epilepsia 2010;51 Suppl 5:1–5.
   PubMed Web of Science ®Google Scholar
• Qu J, Zhou BT, Yin JY, et al. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neurosci Ther 2012;18(8):647–51.
   PubMed Web of Science ®Google Scholar
• Keangpraphun T, Towanabut S, Chinvarun Y, Kijsanayotin P. Association of ABCB1 C3435T polymorphism with phenobarbital resistance in Thai patients with epilepsy. J Clin Pharm Ther 2015; 40(3):315–9.
   PubMed Web of Science ®Google Scholar
• Liu JY, Thom M, Catarino CB, et al. Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy. Brain: J Neurol 2012;135(Pt 10):3115–33.
   Web of Science ®Google Scholar
• Ma CL, Wu XY, Zheng J, et al. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy. Pharmacogenomics 2014;15(10):1323–36.
   PubMed Web of Science ®Google Scholar
• Yun W, Zhang F, Hu C, et al. Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Epilepsy Res 2013;107(3):231–7.
   PubMed Web of Science ®Google Scholar
• Hung CC, Chang WL, Ho JL, et al. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. Pharmacogenomics 2012;13(2):159–69.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tang L, Pan J, et al. The recessive model of MRP2 G1249A polymorphism decrease the risk of drug-resistant in Asian epilepsy: a systematic review and meta-analysis. Epilepsy Res 2015;112:56–63.
   PubMed Web of Science ®Google Scholar
• Yip TS, O'Doherty C, Tan NC, et al. SCN1A variations and response to multiple antiepileptic drugs. Pharmacogenomics J 2014;14(4):385–9.
   PubMed Web of Science ®Google Scholar
• Zhou L, Cao Y, Long H, et al. ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population. Die Pharmazie 2015;70(6):416–20.
   PubMed Web of Science ®Google Scholar
• Kumari R, Lakhan R, Kumar S, et al. SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness. Biochimie 2013;95(6):1350–3.
   PubMed Web of Science ®Google Scholar
• Hilger E, Reinthaler EM, Stogmann E, et al. Lack of association between ABCC2 gene variants and treatment response in epilepsy. Pharmacogenomics 2012;13(2):185–90.
   PubMed Web of Science ®Google Scholar
• Balan S, Bharathan SP, Vellichiramal NN, et al. Genetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistance. PLOS ONE 2014;9(2):e89253.
   PubMed Web of Science ®Google Scholar
• Manna I, Gambardella A, Labate A, et al. Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy. Seizure 2015;24:124–6.
   PubMed Web of Science ®Google Scholar
• Chen P, Yan Q, Xu H, et al. The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature. Genet Test Mol Bioma 2014;18(2):106–11.
   PubMed Web of Science ®Google Scholar
• Seven M, Batar B, Unal S, et al. The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children. Mol Biol Rep 2014;41(1):331–6.
   PubMed Web of Science ®Google Scholar
• Sporis D, Bozina N, Basic S, et al. Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy. Collegium Antropologicum 2013;37(1):41–5.
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Johnson MR. Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr/Am Epilepsy Soc 2008;8(5):127–30.
   PubMedGoogle Scholar
• Fu YH, Lv RJ, Jin LR, et al. Association of apolipoprotein E polymorphisms with temporal lobe epilepsy in a Chinese Han population. Epilepsy Res 2010;91(2–3):253–9.
   PubMed Web of Science ®Google Scholar
• Kauffman MA, Consalvo D, Moron DG, et al. APOE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case-control study and meta-analysis. Epilepsy Res 2010;90(3):234–9.
   PubMed Web of Science ®Google Scholar
• Lien E, Andersen GL, Bao Y, et al. Apolipoprotein E polymorphisms and severity of cerebral palsy: a cross-sectional study in 255 children in Norway. Dev Med Child Neurol 2013;55(4):372–7.
   PubMed Web of Science ®Google Scholar
• Jordan BD. Genetic influences on outcome following traumatic brain injury. Neurochem Res 2007;32(4–5):905–15.
   PubMed Web of Science ®Google Scholar
• Hauser PS, Narayanaswami V, Ryan RO. Apolipoprotein E: from lipid transport to neurobiology. Prog Lipid Res 2011;50(1):62–74.
   PubMed Web of Science ®Google Scholar
• Westmark CJ, Westmark PR, Beard AM, et al. Seizure susceptibility and mortality in mice that over-express amyloid precursor protein. Int J Clin Exp Pathol 2008;1(2):157–68.
   PubMed Web of Science ®Google Scholar
• Palanisamy A, Rajendran NN, Narmadha MP, Ganesvaran RA. Association of apolipoprotein E epsilon4 allele with cognitive impairment in patients with epilepsy and interaction with phenytoin monotherapy. Epilepsy Behav 2013;26(2):165–9.
   PubMed Web of Science ®Google Scholar
• Sporis D, Sertic J, Henigsberg N, et al. Association of refractory complex partial seizures with a polymorphism of APOE genotype. J Cell Mol Med 2005;9(3):698–703.
   PubMed Web of Science ®Google Scholar
• Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51(6):1069–77.
   PubMed Web of Science ®Google Scholar
• Donohoe GG, Salomaki A, Lehtimaki T, et al. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin Chem 1999;45(1):143–6.
   PubMed Web of Science ®Google Scholar
• Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261(5123):921–3.
   PubMed Web of Science ®Google Scholar
• Houlden H, Greenwood R. Apolipoprotein E4 and traumatic brain injury. J Neurol Neurosurg Psychiatr 2006;77(10):1106–7.
   PubMed Web of Science ®Google Scholar
• Aboud O, Mrak RE, Boop FA, Griffin WS. Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype. Acta Neuropathol Commun 2013;1:41.
   PubMedGoogle Scholar
• McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999;53(6):1308–11.
   PubMed Web of Science ®Google Scholar
• Alberts MJ, Graffagnino C, McClenny C, et al. APOE genotype and survival from intracerebral haemorrhage. Lancet 1995;346(8974):575.
   PubMed Web of Science ®Google Scholar
• Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Gen 1996;14(1):55–61.
   PubMed Web of Science ®Google Scholar
• Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000; 71(2):621–9.
   PubMed Web of Science ®Google Scholar
• Friedman G, Froom P, Sazbon L, et al. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999;52(2):244–8.
   PubMed Web of Science ®Google Scholar
• Chapman J, Vinokurov S, Achiron A, et al. APOE genotype is a major predictor of long-term progression of disability in MS. Neurology. 2001;56(3):312–6.
   PubMed Web of Science ®Google Scholar
• Horsburgh K, McCarron MO, White F, Nicoll JA. The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol Aging 2000;21(2):245–55.
   PubMed Web of Science ®Google Scholar
• Montpied P, de Bock F, Lerner-Natoli M, et al. Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity. Epilepsy Res 1999;35(2):135–46.
   PubMed Web of Science ®Google Scholar
• Gouras GK, Relkin NR, Sweeney D, et al. Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol 1997;41(3):402–4.
   PubMed Web of Science ®Google Scholar
• Drage MG, Holmes GL, Seyfried TN. Hippocampal neurons and glia in epileptic EL mice. J Neurocytol 2002;31(8–9):681–92.
   PubMedGoogle Scholar
• Sharma AK, Rani E, Waheed A, Rajput SK. Pharmacoresistant epilepsy: a current update on non-conventional pharmacological and non-pharmacological interventions. J Epilepsy Res 2015;5(1):1–8.
   PubMedGoogle Scholar